These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11574894)

  • 1. Are you part of the Canadian Drug Advertising Self-Regulation System?
    Chepesiuk R
    Can J Clin Pharmacol; 2001; 8(3):131-2. PubMed ID: 11574894
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress in drug advertising.
    McElwain M
    Can Fam Physician; 1997 Jun; 43():1041-2. PubMed ID: 9189283
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 4. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical ads in journals.
    Lexchin J
    Ann Intern Med; 1992 Oct; 117(7):617. PubMed ID: 1524340
    [No Abstract]   [Full Text] [Related]  

  • 6. Standards for pharmaceutical advertising in Canada.
    Chepesiuk R
    CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
    [No Abstract]   [Full Text] [Related]  

  • 7. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
    Desjardins JG
    CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug advertising.
    Bell KD
    Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
    [No Abstract]   [Full Text] [Related]  

  • 9. PAAB: a lesson in self-government.
    Lexchin J
    CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new board for the judgement of drug advertising].
    Lakartidningen; 1969 Aug; 66(35):3442-4. PubMed ID: 5821538
    [No Abstract]   [Full Text] [Related]  

  • 12. The advertising of pharmaceutical preparations.
    WHO Chron; 1969 Jun; 23(6):282-5. PubMed ID: 5793989
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence.
    Smart S; Williams C
    BMJ; 1997 Dec; 315(7122):1622-3. PubMed ID: 9437302
    [No Abstract]   [Full Text] [Related]  

  • 14. A stand against drug company advertising.
    Jelinek GA; Brown AF
    Emerg Med Australas; 2011 Feb; 23(1):4-6. PubMed ID: 21284808
    [No Abstract]   [Full Text] [Related]  

  • 15. Advertising baldly to the public.
    Gandy W
    N Engl J Med; 1992 Jan; 326(5):350-1. PubMed ID: 1728751
    [No Abstract]   [Full Text] [Related]  

  • 16. Capitol Hill panelists want FDA intervention in DTC drug advertising.
    Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 18. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
    Marks JH
    N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
    [No Abstract]   [Full Text] [Related]  

  • 19. Only 6% of drug advertising material is supported by evidence.
    Tuffs A
    BMJ; 2004 Feb; 328(7438):485. PubMed ID: 14999821
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.